Clinical Trials List
Protocol NumberH7U-MC-IDAU
2006-04-01 - 2009-03-31
Phase III
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
-
Update
2025/08/20
Investigators and Locations
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
420 participants
